[1]
|
UNAIDS and WHO, “AIDS Epidemic Update,” Joint United Nations Programme on HIV/AIDS and World Health Organization, Geneva, 2009.
|
[2]
|
R. Steinbrook, “HIV in India—A Downsized Epidemic,” The New England Journal of Medicine, Vol. 358, No. 2, 2008, pp. 107-109. doi:10.1056/NEJMp0708474
|
[3]
|
P. Rerkpattanapipat and N. Woongpraparut, “Cardiac Manifestations of Acquired Immunodeficiency Syndrome,” Archives of Internal Medicine, Vol. 160 No. 5, 2000, pp. 602-608. doi:10.1001/archinte.160.5.602
|
[4]
|
S. Kaul, M. C. Fishbein and R. J. SIEGEL, “Cardiac Manifestations of Acquired Immune Deficiency Syndrome,” American Heart Journal, Vol. 122, No. 2, 1991, pp. 535-544. doi:10.1016/0002-8703(91)91013-D
|
[5]
|
S. Corallo, M. R. Mutinelli, M. Moroni, et al., “Echocardiography Detects Myocardial Damage in AIDS,” European Heart Journal, Vol. 9, No. 8, 1998, pp. 887-892.
|
[6]
|
A. S. Fauci and H. C. Lane, “Human Immunodeficiency Virus Disease: AIDS and Related Disorders,” In: A. S. Fauci, et al., Eds., Harrison’s Principles of Internal Medicine, 18th Edition, McGraw Hill Company Inc., New York/Chicago/New Delhi, 2011, pp. 1506-1587.
|
[7]
|
D. J. Sahn, A. De Maria, J. Kissilo and A. Weyman, “Recommendations Regarding Quantitations in M—Mode Echo Cardiography,” Circulation, Vol. 58, No. 6, 1988, pp. 1072-1083.
|
[8]
|
P. Aggarwal, A. Sharma, R. Bhardwaj and R. Rainam, “Myocardial Dysfunction in Human Immunodeficiency virus Infection: An Echocardiographic Study,” Journal of the Association of Physicians of India, Vol. 57, 2009, pp. 745-746.
|
[9]
|
World Health Organization, “Interim Who Clinical Staging of HIV/AIDS Case Definitions for Surveillance,” 2005.
http://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf
|
[10]
|
National AIDS Control Organization, “A Press Release on HIV Estimates 2009,” 2010.
http://www.nacooline.org/facts
|
[11]
|
B. Anita, et al., “Cardiac Dysfunction Associated with HIV Infection,” Journal of the Association of Physicians of India, Vol. 51, 2003, p. 1182.
|
[12]
|
R. Moreno, J. P. Villacastin, H. Bueno, et al., “Clinical and Echocardiographic Findings in HIV Patients with Pericardial Effusion,” Cardiology, Vol. 88, No. 5, 1997, pp. 397-400. doi:10.1159/000177367
|
[13]
|
J. G. Hakim, J. A. Matenga and S. Siziya, “Myocardial Dysfunction in HIV Infection: An Echocardiographic Study of 157 Patients in Hospital in Zimbabwe,” Heart, Vol. 76, No. 2, 1996, pp. 161-165.
doi:10.1136/hrt.76.2.161
|
[14]
|
A. M. Pellicelli, G. Barbaro, F. Palmieri, E. Girardi, C. D’Ambrosio, A. Rianda, G. Barbarini, D. Frigiotti, M. C. Borgia and N. Petrosillo, “Primary Pulmonary Hypertension in HIV Patients: A Systematic Review,” Angiology, Vol. 52, No. 1, 2001, pp. 31-41.
|
[15]
|
N. J. Mehta, I. A. Khan, R. N. Mehta and D. A. Sepkowitz, “HIV-Related Pulmonary Hypertension: Analytic Review of 131 Cases,” Chest, Vol. 118, No. 4, 2000, pp. 1133-1141. doi:10.1378/chest.118.4.1133
|
[16]
|
M. Mary-Krause, L. Cotter, M. Partisani, A. Simon, D. Costagliola, “Impact of Protease Inhibitor Treatment on Myocardial Infarction in HIV infected Men,” 8th Conference on Retro Virus and Opportunistic Infections, Chicago, 4-8 February 2001.
|
[17]
|
D. Klein, L. B. Hurley, C. P. Quesenberry Jr. and S. Sidney, “Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients with HIV-1 Infection,” Journal of Acquired Immune Deficiency Syndromes, Vol. 30, No. 5, 2002, pp. 471-477.
doi:10.1097/00126334-200208150-00002
|
[18]
|
S. Castro, G. Migliau, A. Silvestri, et al., “Heart Involvement in AIDS: A Prospective Study during Various Stages of Diseases,” European Heart Journal, Vol. 13, 1992, pp. 1452-1459.
|
[19]
|
R. B. Himelman, W. S. Chung, D. N. Chernoff, N. B. Schiller and H. Hollander, “Cardiac Manifestations of Human Immunodeficiency Virus Infection: A Two-Dimensional Echocardiographic Study,” Journal of the American College of Cardiology, Vol. 13, No. 5, 1989, 1030-1036. doi:10.1016/0735-1097(89)90256-8
|
[20]
|
C. Khunnawat, S. Mukerji, D. Havlichek, R. Touma and G. S. Abela, “Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients, American Journal of Cardiology, Vol. 103, No. 2, 2009, pp. 292-293.
|
[21]
|
K. M. Zareba and S. E. Lipshultz, “Cardiovascular Complications in Patients with HIV Infection,” Current Infectious Disease Reports, Vol. 5, No. 6, 2003, pp. 513-520.
doi:10.1007/s11908-003-0096-5
|
[22]
|
G. Barbaro, “Cardiovascular Manifestations of HIV Infection,” Circulation, Vol. 106, 2002, pp. 1420-1425.
doi:10.1161/01.CIR.0000031704.78200.59
|
[23]
|
S. B. Devi, Th. S. D. Singh and R. Ningshen, “Cardovascular Manfestations Of HIV infection/AIDS,” Postgraduate Medicine, Association of Physicians of India, Mumbai, Vol. 55, 2012, pp. 537-550.
|
[24]
|
N. Reinsch, P. Kahlert, S. Esser, A. Sundermeyer, K. Neuhaus, N. Brockmeyer, A. Potthoff, R. Erbel and T. Buck, “Till Neumann Echocardiographic Findings and Abnormalities in HIV Infected Patients: Results from a Large, Prospective, Multicenter HIV-Heart Study. American Journal of Cardiovascular Disease, Vol. 1, No. 2, 2011, pp. 176-184
|